We recently demonstrated that SorLA plays an important role in cancer, where it supports the oncogenic fitness of HER2 by orchestrating HER2 traffic to the plasma membrane, increasing signaling and proliferation in HER2-positive breast cancer [23]. Here, ERBB2 is linked to breast carcinoma.